Michael Rûtzler
1 – 8 of 8
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Characterization of the Aquaporin-9 Inhibitor RG100204 In Vitro and in db/db Mice
(
- Contribution to journal › Article
-
Mark
RG100204, A Novel Aquaporin-9 Inhibitor, Reduces Septic Cardiomyopathy and Multiple Organ Failure in Murine Sepsis
(
- Contribution to journal › Article
- 2021
-
Mark
Ablation of Aquaporin-9 Ameliorates the Systemic Inflammatory Response of LPS-Induced Endotoxic Shock in Mouse
(
- Contribution to journal › Article
- 2020
-
Mark
Stopped-flow Light Scattering Analysis of Red Blood Cell Glycerol Permeability
(
- Contribution to journal › Article
- 2016
-
Mark
Aquaporins : Chemical inhibition by small molecules
2016) p.249-271(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
Deletion of glycerol channel aquaporin-9 (Aqp9) impairs long-term blood glucose control in C57BL/6 leptin receptor-deficient (db/db) obese mice.
(
- Contribution to journal › Article
- 2013
-
Mark
AQP9 Expression in Glioblastoma Multiforme Tumors Is Limited to a Small Population of Astrocytic Cells and CD15(+)/CalB(+) Leukocytes
(
- Contribution to journal › Article
-
Mark
The identification of novel, high affinity AQP9 inhibitors in an intracellular binding site
(
- Contribution to journal › Article